Distinguished Biotech, Pharmaceutical and Healthcare Leaders Will Headline Three Days of Inspiring Innovation at the 24th Annual Conference & Expo, April 2-4 in Boston
BOSTON, March 13, 2025 /PRNewswire/ — Building on its reputation for fostering breakthrough approaches to precision medicine, the 24th annual Bio-IT World Conference & Expo, April 2-4 in Boston, will feature a plenary keynote program of distinguished biotech, pharmaceutical, and healthcare leaders who are harnessing new technologies to push therapeutic boundaries.
“This year’s keynote program is nothing short of extraordinary,” said Cindy Crowninshield, Executive Event Director. “From revolutionizing ALS treatments to reshaping longevity science, our presenters are harnessing AI, quantum computing, data science and more to solve exceptionally difficult problems.”
Headlining three days of inspiring innovations, the plenary sessions will include:
April 2
April 3
April 4
The focus on pushing boundaries will continue with:
Learn more about in-person and virtual sessions at bio-itworldexpo.com.
About Bio-IT World Conference & Expo
For over 20 years, Bio-IT World Conference & Expo has been the premier global event showcasing technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. By uniting a community of experts in life sciences, pharmaceuticals, clinical research, healthcare, informatics, and technology, the event pushes the boundaries of biomedical research, drug discovery and development, and patient outcomes. The program features inspiring plenary keynotes, 200+ educational and technical presentations, interactive panels, hands-on symposia, technical workshops, unparalleled networking opportunities, and an exhibit hall showcasing cutting-edge technologies and solutions. Attendees are invited to engage in transformative conversations on the latest advancements in digital and data transformations; AI; generative AI; machine learning (ML); real-world data strategies; pilot programs; new product results; and biotech investment trends.
SOURCE Bio-IT World Conference & Expo
New multilingual capabilities expand access to real-time GLP-1 dining guidance as WHO highlights the importance…
ATLANTA, GA AND DOHA, QATAR / ACCESS Newswire / December 6, 2025 / Ameerex Corporation…
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…